Trikafta 80-40-60MG/59.5MG PKT 14S
Ended Awarded
- Contract number
- SPE2DB25FX2EH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,314
Award facts
- Contract value 100% obligated
- $19,314.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,314.19 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Trikafta 80-40-60 mg/59.5 mg tablets in quantities of 14 packets. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order with an ultimate completion date of September 8, 2025. No set-aside designation was applied to this contract award. This delivery order was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026, which enables the agency to procure a comprehensive portfolio of pharmaceutical products supporting military healthcare facilities worldwide.
Trikafta is a combination medication used primarily to treat cystic fibrosis, and this award reflects the Defense Logistics Agency's ongoing requirement to maintain adequate pharmaceutical supplies for Department of Defense healthcare operations. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a consistent track record of delivering prescription medications, biologics, and medical consumables to military health facilities. The company's positioning as a woman-owned small business has enabled it to compete effectively in federal procurement markets while maintaining a robust portfolio of federal contract awards across multiple therapeutic categories.
Quick answers
Who was awarded contract SPE2DB25FX2EH?
SPE2DB25FX2EH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FX2EH worth?
The government has obligated $19,314 on SPE2DB25FX2EH.
Is contract SPE2DB25FX2EH an order under another contract?
Yes. SPE2DB25FX2EH is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2EH competed?
The extent of competition for SPE2DB25FX2EH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award